BYOMA ACNE TREATMENT SPOT- salicylic acid paste

Byoma Acne Treatment Spot by

Drug Labeling and Warnings

Byoma Acne Treatment Spot by is a Otc medication manufactured, distributed, or labeled by Byoma Ltd. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Drug Facts

Active Ingredients

Salicylic Acid 2%

Purpose

Acne Treatment

Use

• for the treatment of acne

Warnings

For external use only

When using this product

• skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.

Stop use and ask a doctor if

• skin irritation occurs or gets worse.

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Centre right away.

Directions

• Clean the skin thoroughly before applying this product
• Cover the entire affected area with a thin layer one to three times daily.
• Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor.
• If bothersome dryness or peeling occurs, reduce application to once a day or every other day.

Other Information

Protect the product in this container from excessive heat and direct sun.

Inactive Ingredients

Aqua (Water), Kaolin, Diatomaceous Earth, Cetearyl Alcohol, Glyceryl Stearate, PEG-100 Stearate, Ethyl Linoleate, Phenoxyethanol, Propanediol, Kojic Acid, Glycine Soja (Soybean) Oil, Carthamus Tinctorius (Safflower) Seed Oil, Camphor, Benzyl Alcohol, Sodium Stearoyl Glutamate, Sodium Hydroxide, Phytosphingosine, Ceramide NP, Xanthan Gum, Centella Asiatica Leaf Extract, Ethylhexylglycerin, Bakuchiol, Dehydroacetic Acid, Chlorophyllin-Copper Complex, Rutin, Glycerin, Hydroxycinnamic Acid, Maltodextrin, Sodium Benzoate, Potassium Sorbate.

Questions or Comments?

Contact hello@byoma.com

Product Labeling

INGREDIENTS AND APPEARANCE

BYOMA ACNE TREATMENT SPOT 
salicylic acid paste

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 84821-008
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ)	SALICYLIC ACID	20 mg  in 1 mL

Inactive Ingredients
Ingredient Name	Strength
CENTELLA ASIATICA LEAF (UNII: 6810070TYD)
SODIUM BENZOATE (UNII: OJ245FE5EU)
DEHYDROACETIC ACID (UNII: 2KAG279R6R)
SODIUM COPPER CHLOROPHYLLIN (UNII: 1D276TYV9O)
HYDROXYCINNAMIC ACID (UNII: IBS9D1EU3J)
KAOLIN (UNII: 24H4NWX5CO)
ETHYL LINOLEATE (UNII: MJ2YTT4J8M)
DIATOMACEOUS EARTH (UNII: 2RF6EJ0M85)
GLYCERYL STEARATE (UNII: 230OU9XXE4)
BAKUCHIOL (UNII: OT12HJU3AR)
CERAMIDE NP (UNII: 4370DF050B)
ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)
WATER (UNII: 059QF0KO0R)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
KOJIC ACID (UNII: 6K23F1TT52)
PEG-100 STEARATE (UNII: YD01N1999R)
PROPANEDIOL (UNII: 5965N8W85T)
SODIUM HYDROXIDE (UNII: 55X04QC32I)
CAMPHOR (NATURAL) (UNII: N20HL7Q941)
RUTIN (UNII: 5G06TVY3R7)
BENZYL ALCOHOL (UNII: LKG8494WBH)
SODIUM STEAROYL GLUTAMATE (UNII: 65A9F4P024)
GLYCERIN (UNII: PDC6A3C0OX)
PHYTOSPHINGOSINE (UNII: GIN46U9Q2Q)
CETEARYL ALCOHOL (UNII: 2DMT128M1S)
SOYBEAN OIL (UNII: 241ATL177A)
MALTODEXTRIN (UNII: 7CVR7L4A2D)
SAFFLOWER OIL (UNII: 65UEH262IS)
POTASSIUM SORBATE (UNII: 1VPU26JZZ4)
XANTHAN GUM (UNII: TTV12P4NEE)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 84821-008-01	15 mL in 1 TUBE; Type 0: Not a Combination Product	05/12/2025

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M006	05/12/2025

Labeler - Byoma Ltd (228554984)